Paperpal Prime Logo

Anti-Cancer Agents in Medicinal Chemistry : Impact Factor & More

eISSN: 1875-5992pISSN: 1871-5206

Key Metrics

CiteScore
4
H-Index
103
Impact Factor
< 5
SJR
Q3Pharmacology
SNIP
0.61
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Anti-Cancer Agents in Medicinal Chemistry

Anti-Cancer Agents in Medicinal Chemistry Journal Specifications

Overview
Publisher BENTHAM SCIENCE PUBL LTD
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year2001
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Anti-Cancer Agents in Medicinal Chemistry ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Anti-Cancer Agents in Medicinal Chemistry

Dendritic Cell Vaccines for Glioblastoma: A Systematic Review and Meta-Analysis Comparing New-Onset and Recurrent Cases.
  • 27 Jul 2026
  • Anti-cancer agents in medicinal chemistry
Rechallenge Therapy: New Dimensions in Cancer Therapy.
  • 23 Jul 2026
  • Anti-cancer agents in medicinal chemistry
Emrelis for c-Met Positive NSCLC: A Breakthrough in Antibody-Drug Conjugate-based Treatment Approved by the FDA.
  • 23 Jul 2026
  • Anti-cancer agents in medicinal chemistry
Lazertinib: A Selective EGFR Mutant Inhibitor to Treat Non-Small Cell Lung Cancer.
  • 23 Jul 2026
  • Anti-cancer agents in medicinal chemistry
CDK4/6-Based Drug Research and Development: A Four-Year Update.
  • 21 Jul 2026
  • Anti-cancer agents in medicinal chemistry
CD147 Is Involved in Tanshinone IIA-Induced Reprogramming of the Warburg Effect in Prostate Cancer Cells.
  • 21 Jul 2026
  • Anti-cancer agents in medicinal chemistry
Dendritic Cell Vaccines for Glioblastoma: A Systematic Review and Meta-Analysis Comparing New-Onset and Recurrent Cases.
  • 27 Jul 2026
  • Anti-cancer agents in medicinal chemistry
Rechallenge Therapy: New Dimensions in Cancer Therapy.
  • 23 Jul 2026
  • Anti-cancer agents in medicinal chemistry
Emrelis for c-Met Positive NSCLC: A Breakthrough in Antibody-Drug Conjugate-based Treatment Approved by the FDA.
  • 23 Jul 2026
  • Anti-cancer agents in medicinal chemistry
Lazertinib: A Selective EGFR Mutant Inhibitor to Treat Non-Small Cell Lung Cancer.
  • 23 Jul 2026
  • Anti-cancer agents in medicinal chemistry
CDK4/6-Based Drug Research and Development: A Four-Year Update.
  • 21 Jul 2026
  • Anti-cancer agents in medicinal chemistry
CD147 Is Involved in Tanshinone IIA-Induced Reprogramming of the Warburg Effect in Prostate Cancer Cells.
  • 21 Jul 2026
  • Anti-cancer agents in medicinal chemistry

FAQs on Anti-Cancer Agents in Medicinal Chemistry